JOSEPH THOMIS 4
4 · CESCA THERAPEUTICS INC. · Filed Apr 18, 2018
Insider Transaction Report
Form 4
JOSEPH THOMIS
Director
Transactions
- Disposition to Issuer
Stock Options
2018-04-16−34,000→ 20,000 totalExercise: $3.00Exp: 2028-12-31→ Common Stock (34,000 underlying)
Footnotes (2)
- [F1]The option vests in two (2) installments. 13,500 shares on December 31, 2018 and 6,500 shares on December 31, 2019. Under the terms of the award agreement, no portion of the option may be exercised unless and until the stockholders of the Company approve the November 2017 amendment to our 2016 Equity Incentive Plan and only if such amendment is approved by the stockholders within one year of the adoption of the amendment.
- [F2]34,000 shares of the stock options were cancelled by mutual agreement of the reporting person and Cesca Therapeutics Inc. The reporting person received no cash consideration for the cancellation.